Edition:
United States

Rockwell Medical Inc (RMTI.OQ)

RMTI.OQ on NASDAQ Stock Exchange Global Market

6.71USD
24 May 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$6.71
Open
$6.71
Day's High
$6.71
Day's Low
$6.71
Volume
1,280
Avg. Vol
82,744
52-wk High
$10.56
52-wk Low
$3.55

RMTI.OQ

Chart for RMTI.OQ

About

Rockwell Medical, Inc. (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves... (more)

Overall

Beta: 2.11
Market Cap(Mil.): $349.31
Shares Outstanding(Mil.): 52.06
Dividend: --
Yield (%): --

Financials

  RMTI.OQ Industry Sector
P/E (TTM): -- 14.29 17.36
EPS (TTM): -0.39 -- --
ROI: -26.09 -7.57 -5.72
ROE: -35.59 -7.17 -5.10

BRIEF-Glass Lewis supports election of Mark Ravich to Rockwell Medical board

* Glass Lewis supports election of Mark H. Ravich to Rockwell Medical Inc board

9:06am EDT

BRIEF-Rockwell Medical reports Q1 loss per share $0.09

* Qtrly sales were $14.6 million, or $1.0 million higher than Q1 2016, primarily due to higher domestic sales Source text for Eikon: Further company coverage:

May 09 2017

BRIEF-Richmond Bros. and Mark H. Ravich send letter to Rockwell Medical Shareholders

* Richmond Brothers and Mark H. Ravich send letter to Rockwell Medical Inc Shareholders Source text for Eikon: Further company coverage:

Apr 21 2017

BRIEF-Rockwell Medical Q4 loss per share $0.10

* Qtrly sales were $13.4 million, or $0.7 million lower than q4 2015

Mar 15 2017

BRIEF-Richmond Brothers and Mark Ravich respond to Rockwell Medical lawsuit

* Richmond Brothers Inc and Mark Ravich respond to Rockwell Medical Inc Lawsuit

Mar 09 2017

Rockwell Medical shareholders nominate two directors in proxy fight

NEW YORK Two Rockwell Medical Inc shareholders have launched a proxy fight against the company, nominating themselves to serve as directors on the board.

Mar 02 2017

UPDATE 1-Rockwell Medical shareholders nominate two directors in proxy fight

NEW YORK, March 2 Two Rockwell Medical Inc shareholders have launched a proxy fight against the company, nominating themselves to serve as directors on the board.

Mar 02 2017

Rockwell Medical shareholders launch proxy fight, nominate two directors

NEW YORK, March 2 Two Rockwell Medical Inc. shareholders have launched a proxy fight against the company, nominating themselves to serve as directors on the board.

Mar 02 2017

BRIEF-David Richmond reports 10.8 pct stake in Rockwell Medical

* David Richmond reports 10.8 percent stake in Rockwell Medical Inc as of Feb 20 - sec filing

Feb 21 2017

BRIEF-Rockwell Medical updates progress on Calcitriol commercial launch

* Rockwell Medical updates progress on calcitriol commercial launch

Feb 21 2017

More From Around the Web

Earnings vs. Estimates